Du-Schieng Chien

Title: Du-Schieng Chien: Innovator in Kinase Inhibitors

Introduction

Du-Schieng Chien is a notable inventor based in Guilford, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. With a total of 2 patents, his work focuses on innovative compounds that have the potential to treat various diseases.

Latest Patents

One of Du-Schieng Chien's latest patents involves the creation of new aryl ureas as kinase inhibitors. This invention relates to methods for synthesizing these compounds, which are useful in treating raf mediated diseases, such as cancer. Additionally, his work addresses p38 mediated diseases, including inflammation and osteoporosis, as well as VEGF mediated diseases, which pertain to angiogenesis disorders.

Career Highlights

Du-Schieng Chien is currently associated with Bayer Healthcare LLC, where he continues to advance his research in the pharmaceutical industry. His expertise in the synthesis of aryl ureas has positioned him as a key player in the development of new therapeutic agents.

Collaborations

Throughout his career, Du-Schieng Chien has collaborated with esteemed colleagues, including Jacques P Dumas and William Johnston Scott. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Du-Schieng Chien's contributions to the field of kinase inhibitors exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in various diseases.